Barriers to implementation of the new targeted BCG vaccination in France: A cross sectional study

Vaccine

Volumn 29, Issue 32, 2011, Pages 5232-5237

  Rossignol, L ^a,b   Guthmann, J P ^c   Kerneis S ^a,b   Aubin Auger, I ^d   Lasserre, A ^a,b   Chauvin, P ^a,b   Pelat, C ^a,b   Hanslik, T ^b,e   Levy Bruhl D ^c   Blanchon, T ^a,b  

^a SORBONNE UNIVERSITÉ   (France)

^b INSERM   (France)

^c INSTITUT DE VEILLE SANITAIRE   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

Author keywords

Alternating logistic regression model; BCG vaccine; Epidemiologic factors; General practitioner; Health policy; Infant

Indexed keywords

ADULT; ARTICLE; BCG VACCINATION; FEMALE; FRANCE; GENERAL PRACTITIONER; HEALTH CARE POLICY; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TUBERCULOSIS;

ATTITUDE OF HEALTH PERSONNEL; BCG VACCINE; CROSS-SECTIONAL STUDIES; FEMALE; FRANCE; GENERAL PRACTITIONERS; GUIDELINE ADHERENCE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH POLICY; HUMANS; IMMUNIZATION PROGRAMS; MALE; QUESTIONNAIRES; TUBERCULOSIS; VACCINATION;

EID: 79960332115     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.05.020     Document Type: Article

References (28)

1. Antoine D., Che D. Epidemiology of tuberculosis in France: cases reported in 2008. BEH 2010, 27-28:289-293.
2. de La Rocque F., Cohen R., Vie Le Sage F., Bocquet A., Boucherat M., Levy Bruhl D. French paediatrician and general practitioner's survey about actual and future BCG use. Arch Pediatr 2005, 12(11):1665-1669.
3. Dommergues M.A., de La Rocque F., Guy C., Lecuyer A., Jacquet A., Guerin N., et al. Local and regional adverse reactions to BCG-SSI vaccination: a 12-month cohort follow-up study. Vaccine 2009, 27(50):6967-6973.
4. Levy-Bruhl D., Paty M.C., Antoine D., Bessette D. Recent changes in tuberculosis control and BCG vaccination policy in France. Euro Surveill 2007, 12(9):E070913 3.
5. Groupe de travail du Conseil Supérieur d'Hygiène Publique de France Prévention et prise en charge de la tuberculose en France. Synthèse et recommandations du groupe de travail du Conseil Supérieur d'Hygiène Publique de France (2002-2003). Rev Mal Respir 2003, 20. 7S000-106.
6. Expertise collective Inserm Tuberculose 2004, Place de la vaccination dans la maîtrise de la maladie. Edition Inserm.
7. Levy-Bruhl D. Estimation of the epidemiological impact of various BCG vaccination scenarios in France. Rev Epidemiol Sante Publique 2005, 53(5):501-508.
8. Manissero D., Lopalco P.L., Levy-Bruhl D., Ciofi Degli Atti M.L., Giesecke J. Assessing the impact of different BCG vaccination strategies on severe childhood TB in low-intermediate prevalence settings. Vaccine 2008, 26(18):2253-2259.
9. Société française de santé publique, Synthèse & recommandations de l'audition publique Levée de l'obligation vaccinale par le BCG chez les enfants. Novembre-Décembre 2006 2006.
10. Direction Générale de la Santé Circulaire n°DGS/RI1/2007/318 du 14 août 2007 relative à la suspension de l'obligation de vaccination par le BCG des enfants et adolescents 2007.
11. BEH. 2010 vaccination schedule and recommendations from the " Haut conseil de la santé publique" in France. 2010 [cited 2011 01/11]; Available from: http://www.invs.sante.fr/beh/2010/14_15/beh_14_15.pdf.
12. Infuso A., Falzon D. European survey of BCG vaccination policies and surveillance in children, 2005. Euro Surveill 2006, 11(3):6-11.
13. Romanus V. First experience with BCG discontinuation in Europe. Experience in Sweden 15 years after stopping general BCG vaccination at birth. Bull Int Union Tuberc Lung Dis 1990, 65(2-3):32-35.
14. Romanus V., Svensson A., Hallander H.O. The impact of changing BCG coverage on tuberculosis incidence in Swedish-born children between 1969 and 1989. Tuberc Lung Dis 1992, 73(3):150-161.
15. Romanus V. Selective BCG vaccination in a country with low incidence of tuberculosis. Euro Surveill 2006, 11(3):14-17.
16. Trnka L., Dankova D., Zitova J., Cimprichova L., Migliori G.B., Clancy L., et al. Survey of BCG vaccination policy in Europe: 1994-96. Bull World Health Organ 1998, 76(1):85-91.
17. Trnka L., Dankova D., Svandova E. Six years' experience with the discontinuation of BCG vaccination. 1. Risk of tuberculosis infection and disease. Tuberc Lung Dis 1993, 74(3):167-172.
18. Gordon M., Roberts H., Odeka E. Knowledge and attitudes of parents and professionals to neonatal BCG vaccination in light of recent UK policy changes: a questionnaire study. BMC Infect Dis 2007, 7:82.
19. Guthmann J.P., de La Rocque F., Boucherat M., van Cauteren D., Fonteneau L., Lecuyer A., et al. BCG vaccine coverage in private medical practice: first data in children below two years old, seven months after the end of compulsory vaccination in France. Arch Pediatr 2009, 16(5):489-495.
20. Guthmann J.P., Fonteneau L., Desplanques L., Levy-Bruhl D. BCG vaccination coverage in children born after the end of compulsory BCG vaccination and followed in maternal and child health clinics in France: a national survey 2009. Arch Pediatr 2010, 17(9):1281-1287.
21. Flahault A., Blanchon T., Dorleans Y., Toubiana L., Vibert J.F., Valleron A.J. Virtual surveillance of communicable diseases: a 20-year experience in France. Stat Methods Med Res 2006, 15(5):413-421.
22. Chauvin P., Valleron A.J. Attitude of French general practitioners to the public health surveillance of communicable diseases. Int J Epidemiol 1995, 24(2):435-440.
23. Carey V., Zeger S.L., Diggle P. Modelling multivariate binary data with alternating logistic regressions. Biometrika 1993, 80(3):517-526.
24. Preisser J.S., Arcury T.A., Quandt S.A. Detecting patterns of occupational illness clustering with alternating logistic regressions applied to longitudinal data. Am J Epidemiol 2003, 158(5):495-501.
25. INSEE. Nombre de familles d'immigrés selon le pays d'origine de la personne de référence de la famille. 1999 [cited 2010 June 15]; Recensement de la population: Available from: http://www.insee.fr/fr/themes/tableau.asp%3Freg_id=0%26ref_id=NATCCI02320.
26. Dietz K., Heesterbeek J.A. Bernoulli was ahead of modern epidemiology. Nature 2000, 408(6812):513-514.
27. Spier R.E. Perception of risk of vaccine adverse events: a historical perspective. Vaccine 2001, 20(Suppl. 1):S78-S84. discussion S75-7.
28. Wattrelot P., Brion J.P., Labarere J., Billette de Villemeur A., Girard-Blanc M.F., Stahl J.P., et al. Vaccination practices following the end of compulsory BCG vaccination. A cross-sectional survey of general practitioners and pediatricians. Arch Pediatr 2010, 17(2):118-124.